Nature Communications (Feb 2023)

Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation

  • Marie Bernkopf,
  • Ummi B. Abdullah,
  • Stephen J. Bush,
  • Katherine A. Wood,
  • Sahar Ghaffari,
  • Eleni Giannoulatou,
  • Nils Koelling,
  • Geoffrey J. Maher,
  • Loïc M. Thibaut,
  • Jonathan Williams,
  • Edward M. Blair,
  • Fiona Blanco Kelly,
  • Angela Bloss,
  • Emma Burkitt-Wright,
  • Natalie Canham,
  • Alexander T. Deng,
  • Abhijit Dixit,
  • Jacqueline Eason,
  • Frances Elmslie,
  • Alice Gardham,
  • Eleanor Hay,
  • Muriel Holder,
  • Tessa Homfray,
  • Jane A. Hurst,
  • Diana Johnson,
  • Wendy D. Jones,
  • Usha Kini,
  • Emma Kivuva,
  • Ajith Kumar,
  • Melissa M. Lees,
  • Harry G. Leitch,
  • Jenny E. V. Morton,
  • Andrea H. Németh,
  • Shwetha Ramachandrappa,
  • Katherine Saunders,
  • Deborah J. Shears,
  • Lucy Side,
  • Miranda Splitt,
  • Alison Stewart,
  • Helen Stewart,
  • Mohnish Suri,
  • Penny Clouston,
  • Robert W. Davies,
  • Andrew O. M. Wilkie,
  • Anne Goriely

DOI
https://doi.org/10.1038/s41467-023-36606-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 11

Abstract

Read online

PREGCARE is a new strategy for families who had a child with a pathogenic de novo mutation, that efficiently identifies couples at higher recurrence risk due to parental mosaicism, while reassuring many others that their recurrence risk is negligible.